- Home
- COSM vs LGVN Comparison
COSM vs LGVN Comparison
Compare COSM & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COSM | LGVN |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 11.9M |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | COSM | LGVN |
|---|---|---|
| Price | $0.32 | $0.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 370.4K | ★ 8.5M |
| Earning Date | 05-14-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.58 | ★ 50.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,426,402.00 | $709,000.00 |
| Revenue This Year | $20.69 | N/A |
| Revenue Next Year | $53.10 | $1,183.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $0.28 | $0.48 |
| 52 Week High | $1.32 | $1.83 |
Technical Indicators
Market Signals| Indicator | COSM | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 36.76 | 56.78 |
| Support Level | $0.30 | $0.60 |
| Resistance Level | $0.50 | $0.99 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 27.07 | 39.11 |
Price Performance
Historical ComparisonAbout COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.